chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 1.39
Sex: M
Vaccine: DTAPIPVHIB, HEPA
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Mom called 4/27/11 to our clinic to report that pt's LD was very swelling/red/warm to touch. Advise mom to start putting ice to the affected area & give TYLENOL for discomfort. Mom also reported that child was moving arm w/o problem. Also mom was advised to take him to ER if sx worsen. Pt was treated with 1 dose cephalexin & 1 dose BENADRYL in ED on 4/27/11. Improving by next day.
Age: 2.0
Sex: M
Vaccine: PNC13
Symptoms: Butterfly rash, Erythema, Petechiae, Rash, Scleral haemorrhage
Clinical narrative: Malar rash - not raised on face. Petechial blue - mostly red. Sclera - scattered, small isolated hemorrhages.
Age: 2.0
Sex: M
Vaccine: PNC13
Symptoms: Skin discolouration
Clinical narrative: Malar rash - not raised on face. Petechial blue - mostly red. Sclera - scattered, small isolated hemorrhages.
Age: 5.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: (L) deltoid painful. Moderate swelling informed mom to give TYLENOL prn and cool compresses to site.
Age: 28.0
Sex: F
Vaccine: FLU3, TYP
Symptoms: Injection site anaesthesia, Pain
Clinical narrative: Pt. c/o local pain and numbness to (L) lateral deltoid started at noon. Pt. continues with complaint and was evaluated by Dr. Applied cold pack to area.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Breast pain, Chills, Neuralgia
Clinical narrative: Sharp pain in right breast along nerve path.  Chills.  Pain continues.
Age: 10.0
Sex: F
Vaccine: HEPA, VARCEL
Symptoms: Injection site pruritus, Injection site rash
Clinical narrative: Patient was given Hepatitis A in right deltoid and Varivax in the Left Deltoid. Within 5 minutes pt developed spreading, pruritic rash on skin at left deltoid. No respiratory sxs noted.
Age: 64.0
Sex: M
Vaccine: VARZOS
Symptoms: Neuralgia, Pain in extremity
Clinical narrative: Sharp pain in left arm. Not at injection site.  Following a nerve path. Pain has lessened by still present today.
Age: 5.0
Sex: M
Vaccine: DTAPIPV, DTAPIPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Patient presents 4/29 with right arm red, hot to touch, swollen from elbow to shoulder.  Arm is sore.  Symptoms started morning after infection given.  Appt made by PHN for child to see pediatrician 4/29/11 at 11:15 am.  Appt given to mother.
Age: 5.0
Sex: M
Vaccine: DTAPIPV, DTAPIPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Pt presents today w/ right arm red, hot to touch, swollen from elbow to shoulder. Arm is sore. Symptoms started morning after injection given. Appt made by PHN for child to see Pediatrician 4/29/11 at 11:15 appt given to mother.
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Ataxia, Gait disturbance, Nausea, Presyncope, Vertigo
Clinical narrative: Information has been received from a physician concerning an 18 year old female patient who on 05-SEP-2010, was vaccinated with the first dose of GARDASIL (dose, route and lot number not reported), however no adverse effect was present. On approximately 06-MAR-2011, the patient was vaccinated with the second dose of GARDASIL (dose and route not provided) (Lot number "14372" is an invalid lot number for GARDASIL). The physician reported that on 08-MAR-2011, 24-36 hours after receiving her second dose of GARDASIL, the patient experienced nausea, vomiting, vertigo, near syncope, ataxia, and difficulty walking. The patient did not seek medical attention. No treatment for the adverse events was given. It was reported that the series may be discontinued and the adverse event improved on therapy. The patient recovered on 11-MAR-2011. Follow up information has been received from the Medical assistant (previously reported as physician) who reported that the 18 year old female student patient with no known drug allergies and no known food allergies and no illness at the time of vaccination who on 03-SEP-2010 (previously reported as 05-SEP-2010), was vaccinated with the first dose of GARDASIL intramuscularly on the left deltoid (lot number 666163/0664Z). On 08-MAR-2011, the patient was vaccinated with the second dose of GARDASIL intramuscularly on the left deltoid (Lot number 667866/1437Z). On 09-MAR-2011, the patient experienced nausea, emesis, vertigo, ataxia and near syncope. On 17-MAR-2011, the physician reported that the patient called the office and referred adversities 24-36 hours after inoculation. The physician advised the patient against the third dose of the vaccine. Patient's nausea, emesis, vertigo, ataxia and near syncope were considered to be disabling by the Medical assistant. Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Vomiting
Clinical narrative: Information has been received from a physician concerning an 18 year old female patient who on 05-SEP-2010, was vaccinated with the first dose of GARDASIL (dose, route and lot number not reported), however no adverse effect was present. On approximately 06-MAR-2011, the patient was vaccinated with the second dose of GARDASIL (dose and route not provided) (Lot number "14372" is an invalid lot number for GARDASIL). The physician reported that on 08-MAR-2011, 24-36 hours after receiving her second dose of GARDASIL, the patient experienced nausea, vomiting, vertigo, near syncope, ataxia, and difficulty walking. The patient did not seek medical attention. No treatment for the adverse events was given. It was reported that the series may be discontinued and the adverse event improved on therapy. The patient recovered on 11-MAR-2011. Follow up information has been received from the Medical assistant (previously reported as physician) who reported that the 18 year old female student patient with no known drug allergies and no known food allergies and no illness at the time of vaccination who on 03-SEP-2010 (previously reported as 05-SEP-2010), was vaccinated with the first dose of GARDASIL intramuscularly on the left deltoid (lot number 666163/0664Z). On 08-MAR-2011, the patient was vaccinated with the second dose of GARDASIL intramuscularly on the left deltoid (Lot number 667866/1437Z). On 09-MAR-2011, the patient experienced nausea, emesis, vertigo, ataxia and near syncope. On 17-MAR-2011, the physician reported that the patient called the office and referred adversities 24-36 hours after inoculation. The physician advised the patient against the third dose of the vaccine. Patient's nausea, emesis, vertigo, ataxia and near syncope were considered to be disabling by the Medical assistant. Additional information has been requested.
Age: 71.0
Sex: F
Vaccine: TTOX
Symptoms: Dysphagia, Pharyngeal oedema
Clinical narrative: Initial report received from a consumer, who was the patient, via another manufacturer on 22 April 2011. A 71-year-old female patient with medical history of allergy to pain medicine, received in 1990's an injection (route and site not reported) of TETANUS TOXOID, manufacturer and lot number not reported. The patient reported that "my throat swelled to the point where I could not swallow". The outcome was reported as recovered. No further information was provided. The subjects had another SAE captured in case 2011-02453. Documents held by sender: None.
Age: 41.0
Sex: F
Vaccine: MMR
Symptoms: Erythema, Influenza like illness, Malaise, Pain, Pyrexia
Clinical narrative: On 4/28/11 client noticed back of arm was warm, red and tender. 4/29/11 she developed flu-like symptoms of body aches, malaise and fever of 101. Fever has continued through today (5/3/11). On 5/2/11 she developed a red raised rash all over her body except for her legs. She states the rash is "itchy" at times. She spoke to her MD and he told her he thought she had a mild case of rubella and should stay home. No other treatment.
Age: 41.0
Sex: F
Vaccine: MMR
Symptoms: Rash generalised, Rash pruritic, Rubella, Skin warm, Tenderness
Clinical narrative: On 4/28/11 client noticed back of arm was warm, red and tender. 4/29/11 she developed flu-like symptoms of body aches, malaise and fever of 101. Fever has continued through today (5/3/11). On 5/2/11 she developed a red raised rash all over her body except for her legs. She states the rash is "itchy" at times. She spoke to her MD and he told her he thought she had a mild case of rubella and should stay home. No other treatment.
Age: 15.0
Sex: M
Vaccine: HPV4
Symptoms: Dizziness
Clinical narrative: Patient complained of lightheadedness, no chest pain, no shortness of breath, no weakness. Vital signs normal. Physical exam normal. Patient allowed to rest supine for 20 minutes. Vital signs and physical exam rechecked, both normal. Patient allowed to leave with strict instructions to return if symptoms returned.
Age: 40.0
Sex: M
Vaccine: TDAP
Symptoms: Pain in extremity
Clinical narrative: On 4/27/2011 complained he had arm pain since injection. Called again on 5/1/2011 and was seen by the APN. No signs of erythema, swelling, has not missed work.
Age: 49.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Abasia, Central nervous system lesion, Computerised tomogram, Hypoaesthesia, Immunoglobulin therapy
Clinical narrative: Initial report received from a consumer on 26 April 2011. A 50-year-old male patient with a medical history of a myocardial infarction with stents in July 2010 and diabetes, received on 31 August 2010 an upper arm injection (route not provided) of FLUZONE, sanofi pasteur lot number U3652AA. His concomitant medications included oral hypoglycemics, PLAVIX and LANTUS. The patient had no previous doses of FLUZONE. One month after receiving the vaccine and reported as September 2010, the patient developed numbness on the top of his right knee and then eventually spread to the left knee. He required hospitalization. The patient reported that he could no longer walk. He had a computed tomography (CAT) scans, magnetic resonance imaging (MRI) scans and a spinal tap. A test (not specified) showed lesions on the spine. He stated he was diagnosed with transverse myelitis and paralysis from the waist down. He was treated with MEDROL pack, intravenous immunoglobulin (IVIG) and Plasmapheresis. The outcome was reported as not recovered. Documents held by sender: None.
Age: 49.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Laboratory test abnormal, Lumbar puncture, Myelitis transverse, Nuclear magnetic resonance imaging, Paralysis
Clinical narrative: Initial report received from a consumer on 26 April 2011. A 50-year-old male patient with a medical history of a myocardial infarction with stents in July 2010 and diabetes, received on 31 August 2010 an upper arm injection (route not provided) of FLUZONE, sanofi pasteur lot number U3652AA. His concomitant medications included oral hypoglycemics, PLAVIX and LANTUS. The patient had no previous doses of FLUZONE. One month after receiving the vaccine and reported as September 2010, the patient developed numbness on the top of his right knee and then eventually spread to the left knee. He required hospitalization. The patient reported that he could no longer walk. He had a computed tomography (CAT) scans, magnetic resonance imaging (MRI) scans and a spinal tap. A test (not specified) showed lesions on the spine. He stated he was diagnosed with transverse myelitis and paralysis from the waist down. He was treated with MEDROL pack, intravenous immunoglobulin (IVIG) and Plasmapheresis. The outcome was reported as not recovered. Documents held by sender: None.
Age: 49.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Plasmapheresis
Clinical narrative: Initial report received from a consumer on 26 April 2011. A 50-year-old male patient with a medical history of a myocardial infarction with stents in July 2010 and diabetes, received on 31 August 2010 an upper arm injection (route not provided) of FLUZONE, sanofi pasteur lot number U3652AA. His concomitant medications included oral hypoglycemics, PLAVIX and LANTUS. The patient had no previous doses of FLUZONE. One month after receiving the vaccine and reported as September 2010, the patient developed numbness on the top of his right knee and then eventually spread to the left knee. He required hospitalization. The patient reported that he could no longer walk. He had a computed tomography (CAT) scans, magnetic resonance imaging (MRI) scans and a spinal tap. A test (not specified) showed lesions on the spine. He stated he was diagnosed with transverse myelitis and paralysis from the waist down. He was treated with MEDROL pack, intravenous immunoglobulin (IVIG) and Plasmapheresis. The outcome was reported as not recovered. Documents held by sender: None.
Age: 0.2
Sex: M
Vaccine: DTAPIPVHIB, PNC, RVX
Symptoms: Listless, Unresponsive to stimuli
Clinical narrative: Initial report was received 26 April 2011 from a health care professional. An 11-week-old male patient who had a history of pre-term delivery and reflux, had received a first dose of intramuscular right thigh injection of PENTACEL, lot number C3733AA, and an intramuscular right thigh injection of PREVNAR (lot number E70195), and an oral dose of Rotavirus (Other manufacturer, lot number 1660Z) on 19 April 2011 and three days later in the evening, the patient was listless and unresponsive. He was taken to the emergency room and subsequently admitted. On 26 April 2011, the patient was scheduled for a follow-up visit with their pediatrician. The patient had no concurrent illness at the time of vaccination and he had been taking "PREVICID" concomitantly. The patient's outcome was not reported. Documents held by sender: None.
Age: 1.25
Sex: F
Vaccine: MMR, VARCEL, MMRV
Symptoms: Blood culture negative, Electroencephalogram normal, Full blood count normal, Grand mal convulsion, Metabolic function test
Clinical narrative: Information has been received from a physician concerning a 15 month old patient who on an unknown date on the same day, was vaccinated with MMR II and VARIVAX (Lot numbers not reported). The physician reported that the patient started to experience 6 seizures over the course of 24 hours after vaccination. The patient was hospitalized for an unspecified period of time, and during the hospitalization the patient was treated with an unspecified "anti-seizure" medication. Subsequently, the patient was discharged from the hospital on an unspecified date and had not experienced any further seizures. At the time of the report, the patient had recovered from the experience. Follow up information has been received from the physician concerning the 15 month old female patient with no pertinent medical history, no drug reactions or allergies and no birth defects and fever, no adverse events following prior vaccination and fever at the time of vaccination, who on 01-MAR-2011 was vaccinated subcutaneously with first dose of VARIVAX (Lot number 667240/0675Z) and first dose of MMR II (lot number 667246/09072) at 8:48 A.M. The physician reported that on 06-MAR-2011 and 07-MAR-2011 the patient had fever and on 07-MAR-2011 at 00:30 the patient experienced six tonic-clonic seizures, all less than 5 minutes over 48 hours. The patient was hospitalized for 3 days. On an unspecified date, complete blood cell count (CBC), comprehensive metabolic panel (CMP), blood culture and electroencephalography (EEG) were performed and all of them showed normal results. At the time of the report, the patient's outcome for fever was unknown. Additional information has been requested.
Age: 1.25
Sex: F
Vaccine: MMR, VARCEL, MMRV
Symptoms: Metabolic function test normal, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 15 month old patient who on an unknown date on the same day, was vaccinated with MMR II and VARIVAX (Lot numbers not reported). The physician reported that the patient started to experience 6 seizures over the course of 24 hours after vaccination. The patient was hospitalized for an unspecified period of time, and during the hospitalization the patient was treated with an unspecified "anti-seizure" medication. Subsequently, the patient was discharged from the hospital on an unspecified date and had not experienced any further seizures. At the time of the report, the patient had recovered from the experience. Follow up information has been received from the physician concerning the 15 month old female patient with no pertinent medical history, no drug reactions or allergies and no birth defects and fever, no adverse events following prior vaccination and fever at the time of vaccination, who on 01-MAR-2011 was vaccinated subcutaneously with first dose of VARIVAX (Lot number 667240/0675Z) and first dose of MMR II (lot number 667246/09072) at 8:48 A.M. The physician reported that on 06-MAR-2011 and 07-MAR-2011 the patient had fever and on 07-MAR-2011 at 00:30 the patient experienced six tonic-clonic seizures, all less than 5 minutes over 48 hours. The patient was hospitalized for 3 days. On an unspecified date, complete blood cell count (CBC), comprehensive metabolic panel (CMP), blood culture and electroencephalography (EEG) were performed and all of them showed normal results. At the time of the report, the patient's outcome for fever was unknown. Additional information has been requested.
Age: 1.25
Sex: F
Vaccine: MMR, VARCEL, MMRV
Symptoms: Electroencephalogram normal, Febrile convulsion, Grand mal convulsion, Lumbar puncture normal, Movement disorder
Clinical narrative: Information has been received from a physician concerning a 15 month old patient who on an unknown date on the same day, was vaccinated with MMR II and VARIVAX (Lot numbers not reported). The physician reported that the patient started to experience 6 seizures over the course of 24 hours after vaccination. The patient was hospitalized for an unspecified period of time, and during the hospitalization the patient was treated with an unspecified "anti-seizure" medication. Subsequently, the patient was discharged from the hospital on an unspecified date and had not experienced any further seizures. At the time of the report, the patient had recovered from the experience. Follow up information has been received from the physician concerning the 15 month old female patient with no pertinent medical history, no drug reactions or allergies and no birth defects and fever, no adverse events following prior vaccination and fever at the time of vaccination, who on 01-MAR-2011 was vaccinated subcutaneously with first dose of VARIVAX (Lot number 667240/0675Z) and first dose of MMR II (lot number 667246/09072) at 8:48 A.M. The physician reported that on 06-MAR-2011 and 07-MAR-2011 the patient had fever and on 07-MAR-2011 at 00:30 the patient experienced six tonic-clonic seizures, all less than 5 minutes over 48 hours. The patient was hospitalized for 3 days. On an unspecified date, complete blood cell count (CBC), comprehensive metabolic panel (CMP), blood culture and electroencephalography (EEG) were performed and all of them showed normal results. At the time of the report, the patient's outcome for fever was unknown. Additional information has been requested.
Age: 1.25
Sex: F
Vaccine: MMR, VARCEL, MMRV
Symptoms: Nuclear magnetic resonance imaging normal, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 15 month old patient who on an unknown date on the same day, was vaccinated with MMR II and VARIVAX (Lot numbers not reported). The physician reported that the patient started to experience 6 seizures over the course of 24 hours after vaccination. The patient was hospitalized for an unspecified period of time, and during the hospitalization the patient was treated with an unspecified "anti-seizure" medication. Subsequently, the patient was discharged from the hospital on an unspecified date and had not experienced any further seizures. At the time of the report, the patient had recovered from the experience. Follow up information has been received from the physician concerning the 15 month old female patient with no pertinent medical history, no drug reactions or allergies and no birth defects and fever, no adverse events following prior vaccination and fever at the time of vaccination, who on 01-MAR-2011 was vaccinated subcutaneously with first dose of VARIVAX (Lot number 667240/0675Z) and first dose of MMR II (lot number 667246/09072) at 8:48 A.M. The physician reported that on 06-MAR-2011 and 07-MAR-2011 the patient had fever and on 07-MAR-2011 at 00:30 the patient experienced six tonic-clonic seizures, all less than 5 minutes over 48 hours. The patient was hospitalized for 3 days. On an unspecified date, complete blood cell count (CBC), comprehensive metabolic panel (CMP), blood culture and electroencephalography (EEG) were performed and all of them showed normal results. At the time of the report, the patient's outcome for fever was unknown. Additional information has been requested.
Age: 64.0
Sex: M
Vaccine: PPV
Symptoms: Body temperature increased, Nausea, Oedema peripheral, Tremor
Clinical narrative: Nausea, shaky, (L) arm swollen. Went to ED - IV fluids given. Had temp of 102.
Age: 63.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: 15 x 18 cm area of redness in location of Tdap administration, painful & itchy.
Age: 3.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: PCV-13 administered on 4-27-2011. Parent called & was seen on 4-30-11 for (L) arm redness & warmth at site of vaccine injection.
Age: 11.0
Sex: F
Vaccine: HEPA, HPV4, MNQ, TDAP
Symptoms: Erythema, Induration, Skin warm, Tenderness
Clinical narrative: 3 inch in diameter erythematous area with induration and increased temperature, mildly tender to palpation to the right forearm.
Age: 1.0
Sex: F
Vaccine: DTAPIPVHIB, HEPA, MMR, VARCEL
Symptoms: Cyanosis, Dyspnoea, Immediate post-injection reaction
Clinical narrative: Lips turned blue and gasping for air immediately vaccines were administer by the pediatric resident. Patient were administer epinephrine, given O2 and PO prednisolone. Patient was sent home after recovering with PO BENADRYL.
Age: 9.0
Sex: M
Vaccine: HPV4, VARCEL
Symptoms: Headache, Pyrexia
Clinical narrative: Started running fever on 4/18/11 around 4:30 pm and had headache. Fever 102.0 degrees 6am 4/19/11. No c/o headache this AM. Mother has given him Ibuprofen this am. She was instructed to give him tepid bath or sponge bath. Continues Ibuprofen and TYLENOL alternated as per Dr. If fever increases and continues to contact Dr. If disoriented, neck pain, increased fever, increased HA go to ER or call ambulance.
Age: 88.0
Sex: F
Vaccine: UNK
Symptoms: Oedema peripheral, Pain in extremity, Pruritus
Clinical narrative: Pain and swelling left upper arm. Itching. Rx'd with TOPICORT.
Age: 67.0
Sex: F
Vaccine: HEPAB, TDAP, TYP
Symptoms: Injection site mass, Injection site pruritus, Vaccination site discolouration, Vaccination site warmth
Clinical narrative: Patient describes reaction two days after being vaccinated at Travel Clinic. She c/o "lump and 6 in. black & blue, hot and itchy" on the left arm around or close to vaccination site. Took 1 week to clear.
Age: 5.0
Sex: F
Vaccine: MMRV
Symptoms: Injection site erythema
Clinical narrative: Red area 3cm where vaccine given.
Age: 10.0
Sex: M
Vaccine: PPV
Symptoms: Rash erythematous, Swelling
Clinical narrative: Red rash, minimal swelling, pt. prescribed hydroxyzine 25 mg.
Age: 8.0
Sex: F
Vaccine: PPV
Symptoms: Injection site swelling, Rash erythematous
Clinical narrative: Red rash, swelling from injection site to elbow. Pr prescribed hydroxyzine.
Age: 11.0
Sex: M
Vaccine: TDAP, VARCEL
Symptoms: Cellulitis, Injection site erythema, Injection site swelling, Injection site warmth, Staphylococcal infection
Clinical narrative: Right upper arm became red, hot, swollen where Varicella vaccine was given. Area of redness spread >1 inch over 24hrs. Patient taken to Emergency Room & was diagnosed with staph infection/cellulitis per mom. Prescribed BACTRIM and KEFLEX for 7 days. Symptoms resolved 5 days after onset.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site reaction, Skin lesion
Clinical narrative: 9.5 cm x 5.0 cm erythematous lesion surrounding site of injection - upper (R) thigh.
Age: 0.51
Sex: M
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Blood immunoglobulin G normal, Blood immunoglobulin M normal, Genital rash, Injection site pruritus, Injection site rash
Clinical narrative: Bumps to arms, legs, private area itches. On 4.15.11 rash getting worse. Seen in ER. Rash spreading saw Dr. on 4-18-11 was told it was a reaction from the shots.
Age: 0.51
Sex: M
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Pruritus genital, Rash
Clinical narrative: Bumps to arms, legs, private area itches. On 4.15.11 rash getting worse. Seen in ER. Rash spreading saw Dr. on 4-18-11 was told it was a reaction from the shots.
Age: 0.34
Sex: F
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Vomiting
Clinical narrative: Vomiting 4 times after vaccination.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Left swollen arm, red and painful at touch.
Age: 62.0
Sex: M
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Redness and swelling of upper left arm down to elbow
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMRV, PNC
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site swelling, Local reaction
Clinical narrative: Pt received DTaP, PREVNAR on Rt leg & PROQUAD, IPV on Left leg on 4/19/11. Developed red, swollen, painful local reactions at site - (L) leg was 3cm but (R) leg was 13 x 14 cm area of redness, induration, tender.
Age: 4.0
Sex: M
Vaccine: MMR, PNC13, VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Rt arm swelling and redness which is improving x 24 hours with no treatment needed.
Age: 0.91
Sex: M
Vaccine: DTAPHEPBIP
Symptoms: Erythema, Induration, Inflammation
Clinical narrative: Inflammation/induration 30 mm, - redness.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Pyrexia, Vaccine positive rechallenge
Clinical narrative: Fever, had similar fever after 12 month Varicella, PCV7, DPaT & purulent URI.
Age: 28.0
Sex: F
Vaccine: TDAP
Symptoms: Abdominal pain, Nausea, Pyrexia
Clinical narrative: > 24 hours after vacc given developed severe nausea, some abdominal cramping, low grade fever.
Age: 59.0
Sex: F
Vaccine: FLU3
Symptoms: Neck pain, Nuchal rigidity
Clinical narrative: The day after receiving flu vaccine, she reported neck rigid & very painful. Has had similar reaction with previous flu shots (no fever).
Sex: M
Vaccine: FLU3, HPV4
Symptoms: Abdominal pain, Dizziness, Pallor
Clinical narrative: Abdominal pain, dizziness, pallor after giving vaccines.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Discomfort, Induration, Mass, Neck pain, Rash erythematous
Clinical narrative: Shingles vaccine. Sore, red rash 1.5 "; sore, hard swollen lump size of half a gpoose egg; pain in neck cords on same side as vaccine (left). Maximum discomfort at 2-3 days following vaccination.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Swelling
Clinical narrative: Shingles vaccine. Sore, red rash 1.5 "; sore, hard swollen lump size of half a gpoose egg; pain in neck cords on same side as vaccine (left). Maximum discomfort at 2-3 days following vaccination.
Age: 4.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site swelling, Pyrexia
Clinical narrative: Swelling at the injection site, fever. AUGMENTIN given for seven days. Reaction to PREVNAR 13.
Age: 15.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site cellulitis, Injection site erythema, Injection site pain, Injection site vesicles, Injection site warmth
Clinical narrative: 3 days after vaccination - red area at injection site increased to 3 x 3 warm to touch, & sore. Was seen in office 4-26-11 - red area 4 x 5 in, erythema, hot to touch, & several small vesicles inside red area. Dx with cellulitis vs. vaccination reaction (localized varicella likely) given KEFLEX x 7 days.
Age: 15.0
Sex: F
Vaccine: VARCEL
Symptoms: Vaccination site reaction, Varicella post vaccine
Clinical narrative: 3 days after vaccination - red area at injection site increased to 3 x 3 warm to touch, & sore. Was seen in office 4-26-11 - red area 4 x 5 in, erythema, hot to touch, & several small vesicles inside red area. Dx with cellulitis vs. vaccination reaction (localized varicella likely) given KEFLEX x 7 days.
Age: 29.0
Sex: F
Vaccine: VARCEL
Symptoms: Diarrhoea, Headache, Nausea, Pyrexia
Clinical narrative: Pt. states she had nausea & fever 102 degrees that night, also a headache. She reports diarrhea the following day, with 99 degrees T.
Sex: F
Vaccine: HPV2
Symptoms: Fall, Head injury, Loss of consciousness, Malaise
Clinical narrative: This case was reported by a physician via a sales representative and described the occurrence of passing out in a female subject of unspecified age who was vaccinated with CERVARIX (GlaxoSmithKline). On an unspecified date in 2011 (believed to be in the last couple of weeks) the subject received unspecified dose of CERVARIX. Within 10 minutes of receiving the CERVARIX vaccination, the subject indicated that she did not feel well and then passed out, slumped to the floor and hit her head. The subject was kept in the office and observed for almost an hour because she kept saying she did not feel well. The overall outcome was not known. No additional details were reported.
Age: 53.0
Sex: F
Vaccine: FLUX, TDAP
Symptoms: Anosmia, Computerised tomogram head, Nasoendoscopy, Parosmia
Clinical narrative: Within 24 hrs. of vaccine I lost my sense of smell.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Erythema, Local reaction, Oedema peripheral, Pain in extremity, Skin warm
Clinical narrative: Localized reaction in arm - red, swollen, warm to touch, painful.
Age: 4.0
Sex: M
Vaccine: HIBV, PNC13
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Rt arm swollen and painful. The patient is a 4 year old male. Had pneumo and hib injection 3 days ago and yesterday arm was erythematous and swollen today it is more so and pruritic. No hx allergies. Child had 4 yr imm a few weeks ago and had similar reaction but not as large.
Age: 1.5
Sex: M
Vaccine: MMR
Symptoms: Increased upper airway secretion, Productive cough, Pyrexia
Clinical narrative: Mucousy cough that has progressively become worse over the last 48 hours. Mild fever (100F and below) started on morning of 05/04/2011. Fever broke in response to acetaminophen. Child is otherwise in good spirits despite the impeding cough.
Age: 48.0
Sex: F
Vaccine: FLU3
Symptoms: Blood test, Eye swelling, Pruritus generalised, Swelling face
Clinical narrative: Shortly after receiving flu shot began to itch over entire body.  Next day, eyes and face were swollen, body itchy. Took Benadryl with no relief.  Went to hospital ER, had "shots" with no relief.  Went to allergist who prescribed a "pill" which helped.
Age: 71.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Informed by wife that a couple days after they were vaccinated patient came down with shingles and was seen by Dr for a mild outbreak.
Age: 27.0
Sex: F
Vaccine: DTAP
Symptoms: Asthenia, Condition aggravated, Convulsion, Feeling abnormal, Loss of consciousness
Clinical narrative: 3 minute seizure (loss of consciousness & biting tongue). Severe pain in both shoulders. Shoulders feel disclocated with increasing pain & decreased strength in arms.
Age: 27.0
Sex: F
Vaccine: DTAP
Symptoms: Musculoskeletal pain, Pain, Tongue biting
Clinical narrative: 3 minute seizure (loss of consciousness & biting tongue). Severe pain in both shoulders. Shoulders feel disclocated with increasing pain & decreased strength in arms.
Age: 0.17
Sex: F
Vaccine: DTAPHEPBIP, PPV, RV1
Symptoms: Vomiting
Clinical narrative: My baby got her 2 month old vaccine two weeks ago. The day after the shots, she started vomiting once every day in very large quantity. She never vomited before the vaccination. It was not projectile vomiting but it was at least 2-3 ounces at a time.
Age: 11.0
Sex: M
Vaccine: FLU3, HEPA, MNQ, TDAP
Symptoms: Muscular weakness, Pyrexia
Clinical narrative: Per mom on 4/16/11 pt. had fever of 103 degrees F and "weakness in legs". Offered appt. but declined.
Age: 14.0
Sex: F
Vaccine: HPV4, VARCEL
Symptoms: Erythema
Clinical narrative: Red area on left arm.
Age: 74.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site oedema, Injection site pain
Clinical narrative: Complete upper arm erythema, edema & pain - same arm as injection.
Age: 10.0
Sex: M
Vaccine: TDAP
Symptoms: Erythema, Tenderness
Clinical narrative: C/O - redness, tenderness over (L) deltoid. Dx: possible cellulitis. (5/4/11) Tx: KEFLEX 250/tsp - 2 tsp PO TID x 10 days.
Age: 11.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Rash
Clinical narrative: Had been an amoxicillin x 1 week & then had 2 vaccines at 5:05 pm. Mother reports that rash began around 6:30 pm & pt was taken to ER. She was given BENADRYL.
Age: 0.51
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC13
Symptoms: Injection site atrophy, Injection site discolouration
Clinical narrative: Pt received vaccines on 11-1-10 age 6 mos. Mother reports area on (L) leg noted at age 9 mos. Mother reports area grew in size and indention got worse. Pt saw Dr on 5/2/11 age 1 year and has referred pt to another doctor for evaluation. (L) lateral thigh has purplish appearing, sunken, non tender area 20 x 25 mm.
Age: 32.0
Sex: M
Vaccine: ANTH, MMR, TDAP
Symptoms: Decreased appetite, Dyspnoea, Lymphadenopathy, Nausea, Pharyngeal oedema
Clinical narrative: Developed nausea, cervical and axillary LAD, fever, swelling in throat, difficulty breathing, anorexia x 3 ds. Sxs began soon after receiving vaccines. No prior rx from anthrax 1 except local rx and nodule that persisted 3 months.
Age: 32.0
Sex: M
Vaccine: ANTH, MMR, TDAP
Symptoms: Pyrexia
Clinical narrative: Developed nausea, cervical and axillary LAD, fever, swelling in throat, difficulty breathing, anorexia x 3 ds. Sxs began soon after receiving vaccines. No prior rx from anthrax 1 except local rx and nodule that persisted 3 months.
Age: 1.0
Sex: F
Vaccine: HEP, VARCEL
Symptoms: Dermatitis diaper, Injection site cellulitis, Injection site rash
Clinical narrative: Patient seen on 4-23-11 at U/C for rash on (L) thigh near injection site which showed up 3 days prior. Also seen for diaper rash. Diagnosed as cellulitis of (L) thigh & put on KEFLEX. PCP f/u in 2-3 days.
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site reaction, Rash pruritic
Clinical narrative: Itchy rash at injection site.
Age: 16.0
Sex: F
Vaccine: HPV4, MNQ
Symptoms: Crying, Malaise, Posture abnormal
Clinical narrative: 512PM MENACTRA .5cc IM RD, patient stated did not like needles. Sitting GARDASIL (HPV vaccine) #2 given 0.5cc IM LD. Less than 1 minute pt stated didn't feel well. Upon my ret w/ wheelchair, pt hunched over arms across & tonic. Awakened crying after ammonia inhalant.
Age: 56.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site warmth, Pain
Clinical narrative: TDaP injection 4-22-11. Pain for the next 2 days. 04:30 am 4-25-11 noted warmth, erythema 2 x 7" around injection site. Has allergy to Thimerosal but usually able to take TD vaccine without problems in past (5-7 years ago).
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth, Local reaction
Clinical narrative: As of 4/24 per pt phone call at 2pm - didn't see reaction until 4/23 looking in the mirror. She described the following at the injection site; redness, warmth, swelling and mild itching. Pt using NSAIDS and I suggested use of topical hydrocortisone. Pt denied having any of the following symptoms as of 4/24/11 (when she called):  - (no) tissue pain - (no) fever - (no) blisters - (no) swollen glands - (no) fatigue - (no) headache - (no) hives - (no) blistering - (no) joint pain - (no) muscle pain - (no) increase in hay fever or allergies - (no) drainage, pus - (no) peeling skin. Main concerns: 1) reaction was spreading from 4/23-4/24 down back of arm 2) VIS didn't "explain" the possibility of site reaction 3) reaction possibly evolving into bacterial infection 4) worried due to lack of published information regarding timing (duration) of site reaction. Plan: 1) continue uses NSAIDS (ibuprofen) for inflammation and add OTC hydrocortisone cream for site reaction (pt was resistant to this idea not certain why?) 2) call MD if any of the above sx occurs in next 72 hrs-week 3) call RPh who administered ZOSTAVAX to report on site reaction status 4/25/11 (Monday) as it will be 4 days from time of injection (4/21/11) 4) Review ZOSTAVAX package insert (found online) went over ADR information with pt on the phone & table 2: Injection site and systemic ADR's (days 0- 42). 4/25 Update Pt still having localized rxn. Taking NSAIDS & using hydrocortisone cream. Has not been seen by MD, but pt's husband is ER nurse & will keep an eye on it.
Age: 11.0
Sex: U
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site swelling, Urticaria
Clinical narrative: Redness and swelling, similar to hives in the area directly below the injection site.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site induration, Injection site rash, Injection site swelling
Clinical narrative: Large raised, red, hard rash around injection site. Prednisone and Ranitidine prescribed.
Age: 1.01
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Blood electrolytes, Computerised tomogram head, Electrocardiogram, Electroencephalogram, Grand mal convulsion
Clinical narrative: Patient had 2 minute generalized tonic-clonic seizure 10 hours after receiving vaccines. Mom reported subjectively warm to touch 4 hours prior to seizure & antipyretic given. No fever at ER visit.
Age: 1.01
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Skin warm
Clinical narrative: Patient had 2 minute generalized tonic-clonic seizure 10 hours after receiving vaccines. Mom reported subjectively warm to touch 4 hours prior to seizure & antipyretic given. No fever at ER visit.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMRV
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site warmth
Clinical narrative: Erythema, heat, tenderness & induration extending from deltoid to below elbow of left arm - began day after vaccines given.
Age: 66.0
Sex: M
Vaccine: VARZOS
Symptoms: Chills, Cough, Night sweats, Pain
Clinical narrative: Patient reports of chills & night sweat the day of vaccination, followed by fever, body ache and a slight cough. Pt says he is feeling better now but has a residual cough.
Age: 33.0
Sex: F
Vaccine: FLUN3, FLUN3
Symptoms: Influenza like illness, Intensive care, Pneumonia
Clinical narrative: Pneumonia/flu like symptoms s/p receiving FLUMIST. Vaccine given approx 23rd September w/ onset of symptoms 28th September 2010. Hospitalized on 28 Sept 2010/ICU x18 days.
Age: 33.0
Sex: F
Vaccine: FLUN3, FLUN3
Symptoms: Activated partial thromboplastin time, Acute respiratory distress syndrome, Angioedema, Asthenia, Base excess decreased
Clinical narrative: Pneumonia/flu like symptoms s/p receiving FLUMIST. Vaccine given approx 23rd September w/ onset of symptoms 28th September 2010. Hospitalized on 28 Sept 2010/ICU x18 days.
Age: 33.0
Sex: F
Vaccine: FLUN3, FLUN3
Symptoms: Blood albumin decreased, Blood bicarbonate decreased, Blood calcium decreased, Blood creatine phosphokinase MB normal, Blood creatine phosphokinase normal
Clinical narrative: Pneumonia/flu like symptoms s/p receiving FLUMIST. Vaccine given approx 23rd September w/ onset of symptoms 28th September 2010. Hospitalized on 28 Sept 2010/ICU x18 days.
Age: 33.0
Sex: F
Vaccine: FLUN3, FLUN3
Symptoms: Blood culture negative, Blood glucose increased, Blood pH decreased, Blood urea decreased, Bronchoalveolar lavage normal
Clinical narrative: Pneumonia/flu like symptoms s/p receiving FLUMIST. Vaccine given approx 23rd September w/ onset of symptoms 28th September 2010. Hospitalized on 28 Sept 2010/ICU x18 days.
Age: 33.0
Sex: F
Vaccine: FLUN3, FLUN3
Symptoms: Carbon dioxide decreased, Chest X-ray abnormal, Chest pain, Chest tube insertion, Computerised tomogram thorax normal
Clinical narrative: Pneumonia/flu like symptoms s/p receiving FLUMIST. Vaccine given approx 23rd September w/ onset of symptoms 28th September 2010. Hospitalized on 28 Sept 2010/ICU x18 days.
Age: 33.0
Sex: F
Vaccine: FLUN3, FLUN3
Symptoms: Culture urine negative, Dysphagia, Dyspnoea, Echocardiogram normal, Electrocardiogram ST-T change
Clinical narrative: Pneumonia/flu like symptoms s/p receiving FLUMIST. Vaccine given approx 23rd September w/ onset of symptoms 28th September 2010. Hospitalized on 28 Sept 2010/ICU x18 days.
Age: 33.0
Sex: F
Vaccine: FLUN3, FLUN3
Symptoms: Electrocardiogram ST-T segment depression, Electrocardiogram T wave abnormal, Endotracheal intubation, Fibrin, Gastrointestinal tube insertion
Clinical narrative: Pneumonia/flu like symptoms s/p receiving FLUMIST. Vaccine given approx 23rd September w/ onset of symptoms 28th September 2010. Hospitalized on 28 Sept 2010/ICU x18 days.
Age: 33.0
Sex: F
Vaccine: FLUN3, FLUN3
Symptoms: Granulocyte percentage, Hyperhidrosis, Insomnia, Laboratory test normal, Legionella test
Clinical narrative: Pneumonia/flu like symptoms s/p receiving FLUMIST. Vaccine given approx 23rd September w/ onset of symptoms 28th September 2010. Hospitalized on 28 Sept 2010/ICU x18 days.
Age: 33.0
Sex: F
Vaccine: FLUN3, FLUN3
Symptoms: Liver function test normal, Lung infiltration, Lymphocyte percentage decreased, Malnutrition, Mechanical ventilation
Clinical narrative: Pneumonia/flu like symptoms s/p receiving FLUMIST. Vaccine given approx 23rd September w/ onset of symptoms 28th September 2010. Hospitalized on 28 Sept 2010/ICU x18 days.
Age: 33.0
Sex: F
Vaccine: FLUN3, FLUN3
Symptoms: Middle insomnia, PCO2, PO2, Pneumonia, Pneumonia bacterial
Clinical narrative: Pneumonia/flu like symptoms s/p receiving FLUMIST. Vaccine given approx 23rd September w/ onset of symptoms 28th September 2010. Hospitalized on 28 Sept 2010/ICU x18 days.
Age: 33.0
Sex: F
Vaccine: FLUN3, FLUN3
Symptoms: Pneumothorax, Productive cough, Protein total decreased, Prothrombin time, Purulent discharge
Clinical narrative: Pneumonia/flu like symptoms s/p receiving FLUMIST. Vaccine given approx 23rd September w/ onset of symptoms 28th September 2010. Hospitalized on 28 Sept 2010/ICU x18 days.
Age: 33.0
Sex: F
Vaccine: FLUN3, FLUN3
Symptoms: Pyrexia, Respiratory disorder, Sinus tachycardia, Streptococcus test negative, Tracheostomy
Clinical narrative: Pneumonia/flu like symptoms s/p receiving FLUMIST. Vaccine given approx 23rd September w/ onset of symptoms 28th September 2010. Hospitalized on 28 Sept 2010/ICU x18 days.
Age: 33.0
Sex: F
Vaccine: FLUN3, FLUN3
Symptoms: Troponin I increased, Ultrasound Doppler normal, White blood cell count increased
Clinical narrative: Pneumonia/flu like symptoms s/p receiving FLUMIST. Vaccine given approx 23rd September w/ onset of symptoms 28th September 2010. Hospitalized on 28 Sept 2010/ICU x18 days.
Age: 33.0
Sex: F
Vaccine: FLUN3, FLUN3
Symptoms: Influenza like illness, Intensive care, Pneumonia
Clinical narrative: This is a follow-up to a previously submitted VAERS report unknown, received annual FLUMIST vaccination on 9/23/2010 (MED 501057P). She advised she had a mild cough with a sore scratchy throat for 2 days prior to this vaccination (exposed to friend with strep throat). By 9/26/2010 (3 days post vaccination) she began to experience a purulent productive cough that would wake her up, sweating, fever (greater than 102), shortness of breath (problems inhaling), and inability to sleep. She presented to nearby hospital the next morning 9/27/2010 (day 4 after FLUMIST vaccine and day 6 for symptom onset) and admitted for Community Acquired Pneumonia (CAP). On 9/29/2010, her respiratory status worsened and she complained of chest pain. She was transferred to hospital for emergent intubation (RR 50-60) being diagnosed with ARDS and multilobar bacterial community acquired pneumonia. She required use of high-frequency oscillatory ventilation, 14 days ceftriaxone and 12 days azithromycin, tracheostomy secondary to tongue angioedema unresponsive to steroids, two right chest tubes secondary to tension pneumothorax, and feeding tubes. On 10/22/2010 she was discharged for inpatient rehab with continued improvement and ultimate resolution of ARDS, multilobe bacterial pneumonia, tongue angioedema, dysphagia, debilitation, and severe malnutrition.
Age: 33.0
Sex: F
Vaccine: FLUN3, FLUN3
Symptoms: Activated partial thromboplastin time, Acute respiratory distress syndrome, Angioedema, Asthenia, Base excess decreased
Clinical narrative: This is a follow-up to a previously submitted VAERS report unknown, received annual FLUMIST vaccination on 9/23/2010 (MED 501057P). She advised she had a mild cough with a sore scratchy throat for 2 days prior to this vaccination (exposed to friend with strep throat). By 9/26/2010 (3 days post vaccination) she began to experience a purulent productive cough that would wake her up, sweating, fever (greater than 102), shortness of breath (problems inhaling), and inability to sleep. She presented to nearby hospital the next morning 9/27/2010 (day 4 after FLUMIST vaccine and day 6 for symptom onset) and admitted for Community Acquired Pneumonia (CAP). On 9/29/2010, her respiratory status worsened and she complained of chest pain. She was transferred to hospital for emergent intubation (RR 50-60) being diagnosed with ARDS and multilobar bacterial community acquired pneumonia. She required use of high-frequency oscillatory ventilation, 14 days ceftriaxone and 12 days azithromycin, tracheostomy secondary to tongue angioedema unresponsive to steroids, two right chest tubes secondary to tension pneumothorax, and feeding tubes. On 10/22/2010 she was discharged for inpatient rehab with continued improvement and ultimate resolution of ARDS, multilobe bacterial pneumonia, tongue angioedema, dysphagia, debilitation, and severe malnutrition.
Age: 33.0
Sex: F
Vaccine: FLUN3, FLUN3
Symptoms: Blood albumin decreased, Blood bicarbonate decreased, Blood calcium decreased, Blood creatine phosphokinase MB normal, Blood creatine phosphokinase normal
Clinical narrative: This is a follow-up to a previously submitted VAERS report unknown, received annual FLUMIST vaccination on 9/23/2010 (MED 501057P). She advised she had a mild cough with a sore scratchy throat for 2 days prior to this vaccination (exposed to friend with strep throat). By 9/26/2010 (3 days post vaccination) she began to experience a purulent productive cough that would wake her up, sweating, fever (greater than 102), shortness of breath (problems inhaling), and inability to sleep. She presented to nearby hospital the next morning 9/27/2010 (day 4 after FLUMIST vaccine and day 6 for symptom onset) and admitted for Community Acquired Pneumonia (CAP). On 9/29/2010, her respiratory status worsened and she complained of chest pain. She was transferred to hospital for emergent intubation (RR 50-60) being diagnosed with ARDS and multilobar bacterial community acquired pneumonia. She required use of high-frequency oscillatory ventilation, 14 days ceftriaxone and 12 days azithromycin, tracheostomy secondary to tongue angioedema unresponsive to steroids, two right chest tubes secondary to tension pneumothorax, and feeding tubes. On 10/22/2010 she was discharged for inpatient rehab with continued improvement and ultimate resolution of ARDS, multilobe bacterial pneumonia, tongue angioedema, dysphagia, debilitation, and severe malnutrition.